Headlines about The Joint Corp. (NASDAQ:JYNT) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm identifies positive and negative media coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. The Joint Corp. earned a media sentiment score of 0.18 on Accern’s scale. Accern also assigned news headlines about the company an impact score of 46.7409460099759 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

The Joint Corp. (NASDAQ:JYNT) opened at $5.54 on Monday. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.32 and a quick ratio of 1.32. The Joint Corp. has a one year low of $1.96 and a one year high of $6.00.

The Joint Corp. (NASDAQ:JYNT) last announced its quarterly earnings results on Thursday, November 9th. The company reported ($0.03) EPS for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.03. The firm had revenue of $6.55 million during the quarter, compared to analysts’ expectations of $6.28 million. The Joint Corp. had a negative net margin of 36.74% and a negative return on equity of 98.28%. analysts expect that The Joint Corp. will post -0.27 earnings per share for the current fiscal year.

Several research firms recently weighed in on JYNT. Roth Capital initiated coverage on shares of The Joint Corp. in a research note on Thursday, July 27th. They issued a “buy” rating and a $5.70 target price for the company. Zacks Investment Research upgraded shares of The Joint Corp. from a “hold” rating to a “buy” rating and set a $5.00 price target for the company in a research note on Wednesday, September 27th. Finally, Maxim Group restated a “buy” rating and set a $7.00 price target on shares of The Joint Corp. in a research note on Friday, August 11th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $5.86.

COPYRIGHT VIOLATION WARNING: “Somewhat Favorable Media Coverage Somewhat Unlikely to Affect The Joint Corp. (JYNT) Stock Price” was reported by Daily Political and is the property of of Daily Political. If you are reading this news story on another domain, it was illegally copied and republished in violation of United States and international trademark & copyright law. The correct version of this news story can be read at https://www.dailypolitical.com/2017/11/20/somewhat-favorable-media-coverage-somewhat-unlikely-to-affect-the-joint-corp-jynt-stock-price.html.

About The Joint Corp.

The Joint Corp. develops, owns, operates, supports and manages chiropractic clinics through direct ownership, management arrangements, franchising and the sale of regional developer rights throughout the United States. The Company is franchisor and operator of chiropractic clinics. The Company offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention.

Insider Buying and Selling by Quarter for The Joint Corp. (NASDAQ:JYNT)

Receive News & Ratings for The Joint Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Joint Corp. and related companies with MarketBeat.com's FREE daily email newsletter.